Back to Search
Start Over
LONG-TERM OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON- HODGKIN LYMPHOMA TREATED WITH BISPECIFIC ANTIBODY BLINATUMOMAB IN A PHASE I TRIAL
- Source :
- Hematological Oncology. 37:325-326
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
Details
- ISSN :
- 02780232
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........ffd7c748a3839d411c4da10c0f1b0561